JAAD onlineCollodion-like membrane in a newborn exposed to infliximab
Under a Creative Commons license
open access
Cited by (0)
Funding sources: None.
Disclosure: Dr Brodell is on the speakers bureau for Allergan, Galderma, PharmaDerm (a division of Fougera Pharmaceuticals Inc), and Veregen; a consultant/investigator/advisory board member for Galderma Laboratories LP; and has performed multicenter clinical trials for Genentech and Janssen Biotech Inc. Ms Offiah and Drs Campbell and Wyatt have no conflicts of interest.
Copyright © 2014 American Academy of Dermatology, Inc. Published by Mosby, Inc.